Literature DB >> 20831888

Barrier analysis of periocular drug delivery to the posterior segment.

Veli-Pekka Ranta1, Eliisa Mannermaa1, Kirsi Lummepuro2, Astrid Subrizi3, Antti Laukkanen3, Maxim Antopolsky3, Lasse Murtomäki4, Margit Hornof3, Arto Urtti5.   

Abstract

Periocular administration is a potential way of delivering drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for subconjunctival drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment drug delivery. Theoretical calculations for subconjunctival drug administration indicated that local clearance by the blood flow and lymphatics removes most of the drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new drug delivery strategies for posterior segment of the eye.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831888     DOI: 10.1016/j.jconrel.2010.08.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera.

Authors:  Poonam Chopra; Jinsong Hao; S Kevin Li
Journal:  J Control Release       Date:  2012-01-27       Impact factor: 9.776

2.  Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model.

Authors:  Timothy W Olsen; Xiao Feng; Kathy Wabner; Karl Csaky; Stefan Pambuccian; J Douglas Cameron
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

3.  Prediction of passive drug permeability across the blood-retinal barrier.

Authors:  Aapo Tervonen; Iina Vainio; Soile Nymark; Jari Hyttinen
Journal:  Pharm Res       Date:  2014-03-13       Impact factor: 4.200

4.  Dendrimers for Ocular Drug Delivery.

Authors:  Michael G Lancina; Hu Yang
Journal:  Can J Chem       Date:  2017-05-11       Impact factor: 1.118

Review 5.  Nanocrystal for ocular drug delivery: hope or hype.

Authors:  Om Prakash Sharma; Viral Patel; Tejal Mehta
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

6.  In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.

Authors:  Alys E Davies; Rachel L Williams; Gaia Lugano; Serban R Pop; Victoria R Kearns
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

7.  In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device.

Authors:  Kevin D Lance; Daniel A Bernards; Natalie A Ciaccio; Samuel D Good; Thaís S Mendes; Max Kudisch; Elliot Chan; Mynna Ishikiriyama; Robert B Bhisitkul; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

8.  Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation.

Authors:  Srinivas Rao Chennamaneni; Christina Mamalis; Bonnie Archer; Zack Oakey; Balamurali K Ambati
Journal:  J Control Release       Date:  2013-01-13       Impact factor: 9.776

Review 9.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

10.  Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

Authors:  Amber Dahlin; Ethan Geier; Sophie L Stocker; Cheryl D Cropp; Elena Grigorenko; Michele Bloomer; Julie Siegenthaler; Lu Xu; Anthony S Basile; Diane D-S Tang-Liu; Kathleen M Giacomini
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.